14-day Premium Trial Subscription Try For FreeTry Free
Currently predicting for Mon, 6 May 2024

KIN Predictions History

5 years ago
NameNotImportant predicted that KIN for 2019-04-29 is going $9.42 (-0.32%)

5 years ago
JS predicted that KIN for 2018-08-07 is going $13.96 (3.79%)

5 years ago
JS predicted that KIN for 2018-06-18 is going $10.97 (-1.17%)

5 years ago
pickemall predicted that KIN for 2018-06-19 is going $10.56 (-4.86%)

Rank:

7 years ago
JS predicted that KIN for 2017-03-17 is going $7.10 (4.41%)

7 years ago
Jack.Cesario.Migueis.3576 predicted that KIN for 2017-03-17 is going $6.90 (-2.13%)

7 years ago
shrinemiko predicted that KIN for 2017-03-17 is going $7.24 (2.70%)

Rank:

7 years ago
JS predicted that KIN for 2017-01-17 is going $6.11 (-3.02%)

7 years ago
YoungBulls predicted that KIN for 2017-01-17 is going $6.20 (-1.59%)

Rank:

7 years ago
JS predicted that KIN for 2016-12-01 is going $4.22 (4.20%)

Click to get the best stock tips daily for free!

About Kindred Biosciences

Kindred Biosciences Kindred Biosciences, Inc., a development stage biopharmaceutical company, focuses on the development of therapies for pets. The company’s product pipeline consists of small molecules and biologics for a range of indications in dogs, cats, and horses. Its lead product candidates include Zimeta, a pyrazolone anti-inflammatory drug, for the treatment of fever in horses; and KIND-010 for management of weight loss in cats and feline epo for anemia in... KIN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT